Report Library
All ReportsChronic Neuropathic Pain Survey
December 22, 2016
We performed a 5-question survey of 30 United States neurologists who currently treat patients with chronic neuropathic pain and prescribe
opioids to at least some of their patients with chronic neuropathic pain to gauge current use of adjuvants (TCAs, anti-convulsants, SNRIs,
SSRIs, and NMDA receptor antagonists) and potential future use of cebranopadol and raxatrigine to treat chronic neuropathic pain.
This survey is also included in the Pressures and Opportunities in Pain report.
If you are a KOL Insight Subscriber, please access the survey from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
This survey is also included in the Pressures and Opportunities in Pain report.
If you are a KOL Insight Subscriber, please access the survey from our KOL Insight portal (Subscribers only).
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
Indications Covered: |
Chronic Pain
Neuropathic Pain Sciatica |